Docusign (DOCU)
(Delayed Data from NSDQ)
$71.11 USD
+1.73 (2.49%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $71.29 +0.18 (0.25%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$71.11 USD
+1.73 (2.49%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $71.29 +0.18 (0.25%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum F VGM
Zacks News
This Top Business Services Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Here's How Booz Allen (BAH) Increased 16% in the Past 6 Months
by Zacks Equity Research
Booz Allen's (BAH) Vision 2020 drove sustainable growth, aligning with core missions, deepening technical projects, fostering innovation, expanding partnerships and entering new markets.
Reasons Why APTIV (APTV) Deserves to be Retained by Investors
by Zacks Equity Research
APTIV (APTV) benefits from strong positioning in the connected cars market, driven by acquisition and smart architecture.
Reasons Why You Should Retain ABM Industries (ABM) Stock Now
by Zacks Equity Research
Strategic partnerships and the execution of the plan called ELEVATE are boding well for ABM Industries (ABM).
Reasons Why You Should Hold on to Stericycle (SRCL) Now
by Zacks Equity Research
Stericycle (SRCL) is gaining from its transformation initiative launched in 2017 and its robust acquisition strategy.
Reasons to Retain Trane Technologies (TT) for the Time Being
by Zacks Equity Research
Trane Technologies (TT) is dedicated to improving product quality, operational efficiency, and innovation for sustained earnings and cash flow growth.
Zacks Investment Ideas feature highlights: DocuSign, Walmart and Target
by Zacks Equity Research
DocuSign, Walmart and Target have been highlighted in this Investment Ideas article.
UiPath, Inc. (PATH) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
UiPath (PATH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Top Growth Stocks to Make the Most of Santa Claus Rally
by Nalak Das
We have narrowed our search to five growth stocks that have solid upside left for the rest of 2023. These are: DOCU, DUOL, DVA, VRT, PLTR.
3 Highly-Ranked Stocks to Buy Now for a Big 2024 Comeback
by Benjamin Rains
The three highly-ranked stocks we dig into today--DocuSign (DOCU), Nike (NKE), and Target (TGT)--are all trading at least 30% below their highs and could be poised for serious comebacks in 2024.
Here's Why DocuSign (DOCU) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Rank Explained: How to Find Strong Buy Business Services Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Earnings Estimates Rising for DocuSign (DOCU): Will It Gain?
by Zacks Equity Research
DocuSign (DOCU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why DocuSign (DOCU) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Company News for Dec 11, 2023
by Zacks Equity Research
Companies In The News Are: LULU, AVGO, DOCU, RH.
DocuSign (DOCU) Beats on Q3 Earnings and Revenues
by Zacks Equity Research
DocuSign's (DOCU) third-quarter fiscal 2024 earnings and revenues rise year over year.
DocuSign (DOCU) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for DocuSign (DOCU) give a sense of how its business performed in the quarter ended October 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sprinkler (CXM) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Sprinkler (CXM) delivered earnings and revenue surprises of 57.14% and 3.46%, respectively, for the quarter ended October 2023. Do the numbers hold clues to what lies ahead for the stock?
Reasons Why You Should Retain WEX in Your Portfolio Right Now
by Zacks Equity Research
WEX's organic growth, strategic acquisitions and customer-centric approach drive revenues. The recent Payzer acquisition aligns with its expansion strategy.
Here's Why Insperity (NSP) Deserves to be Retained Right Now
by Zacks Equity Research
Shareholder-friendly attitude bodes well for Insperity (NSP), while competition in the industry is concerning.
Reasons Why Retaining TransUnion (TRU) Can Be a Wise Decision
by Zacks Equity Research
TransUnion (TRU) is gaining from transformation initiatives, acquisitions and collaborations. Competition is concerning.
DocuSign (DOCU) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
DocuSign's (DOCU) third-quarter fiscal 2024 earnings and revenues are expected to increase year over year.
Countdown to DocuSign (DOCU) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for DocuSign (DOCU), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2023.
Zacks.com featured highlights AMC Entertainment, DocuSign, Vivid Seats, Lamb Weston and Fiverr International
by Zacks Equity Research
AMC Entertainment, DocuSign, Vivid Seats, Lamb Weston and Fiverr International have been highlighted in this Screen of The Week article.
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap four stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include AMC Entertainment (AMC), DocuSign (DOCU), Vivid Seats (SEAT), Lamb Weston (LW) and Fiverr International (FVRR).